FLEXION THERAPEUTICS INC's ticker is FLXN and the CUSIP is 33938J106. A total of 131 filers reported holding FLEXION THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 1.34 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $120,000 | -8.4% | 14,725 | -7.5% | 0.00% | – |
| Q2 2021 | $131,000 | -27.2% | 15,925 | -20.9% | 0.00% | – |
| Q1 2021 | $180,000 | +10.4% | 20,140 | +42.2% | 0.00% | – |
| Q4 2020 | $163,000 | +181.0% | 14,164 | +150.0% | 0.00% | – |
| Q3 2020 | $58,000 | +16.0% | 5,665 | -11.8% | 0.00% | – |
| Q1 2020 | $50,000 | -95.5% | 6,426 | -88.0% | 0.00% | -100.0% |
| Q4 2019 | $1,112,000 | +1363.2% | 53,745 | +865.1% | 0.00% | – |
| Q3 2019 | $76,000 | -39.2% | 5,569 | -45.6% | 0.00% | – |
| Q2 2019 | $125,000 | -57.5% | 10,237 | -56.6% | 0.00% | -100.0% |
| Q1 2019 | $294,000 | +62.4% | 23,589 | +153.7% | 0.00% | -91.7% |
| Q3 2016 | $181,000 | +2916.7% | 9,297 | +2178.7% | 0.01% | – |
| Q2 2016 | $6,000 | -92.0% | 408 | -89.6% | 0.00% | -100.0% |
| Q4 2015 | $75,000 | +294.7% | 3,909 | +190.6% | 0.01% | +500.0% |
| Q3 2015 | $19,000 | – | 1,345 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Novo Holdings A/S | 1,097,718 | $21,449,000 | 1.90% |
| GILDER GAGNON HOWE & CO LLC | 3,986,098 | $77,888,000 | 1.34% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,067,621 | $20,861,000 | 0.96% |
| SOUTHPORT MANAGEMENT, L.L.C. | 25,000 | $489,000 | 0.95% |
| WALL STREET ASSOCIATES | 140,500 | $2,745,000 | 0.94% |
| Convector Capital Management, LP | 15,617 | $305,000 | 0.56% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 808,385 | $15,796,000 | 0.53% |
| PEREGRINE CAPITAL MANAGEMENT LLC | 722,905 | $14,126,000 | 0.37% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 100,000 | $1,954,000 | 0.32% |
| WASATCH ADVISORS LP | 823,491 | $16,091,000 | 0.24% |